Targeting "Anti-Tumor" Genes To Improve Treatment of Leukemia
Researchers from École Polytechnique Fédérale de Lausanne (EPFL) are exploring the possibility of personalized treatment for chronic lymphocytic leukemia by regulating the expression of a gene known for its “anti-cancer” properties.
Source: technologynetworks.com